ghk-cu low immunogenicity suppressed the activation of the p38 MAPK signaling pathway in GHK-Cu Copper Tripeptide-1 | Research

And naturally, the internet is treating it like a miracle skinny shot or a dangerous science experiment

The exact amount depends on the patients health, how bad the deficiency is, and how well they respond to treatment

In preparatory documents for the meeting, FDA staff said that it believed the evaluation criteria weigh against placing BPC-157 on the list because there was limited evidence about the peptides effectiveness and because there are other FDA-approved treatments for ulcerative colitis

They offer everything I need for my health, theyre reliable and always on top things

however, they are no longer commonly used in clinical medicine